Lincoln Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
511.05
-0.85 (-0.17%)
BSENSE

Nov 20

BSE+NSE Vol: 16.09 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
20.03
20.03
20.03
20.03
20.03
20.03
Share Warrants & Outstandings
Total Reserve
737.60
651.64
572.81
482.44
412.85
346.36
Shareholder's Funds
757.63
671.67
592.84
502.47
432.88
366.39
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.14
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.14
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
13.53
13.00
11.46
7.94
6.45
5.69
Other Long Term Liabilities
6.44
5.39
3.62
4.72
4.54
4.29
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.76
0.73
0.10
0.14
0.00
0.00
Total Non-Current Liabilities
21.73
19.12
15.18
12.80
10.99
10.13
Current Liabilities
Trade Payables
84.86
84.95
72.44
50.87
71.67
57.07
Other Current Liabilities
15.65
14.78
15.25
15.39
14.12
16.22
Short Term Borrowings
4.42
0.00
1.07
2.00
2.04
0.38
Short Term Provisions
6.11
6.49
3.52
3.89
2.66
2.18
Total Current Liabilities
111.04
106.22
92.28
72.15
90.49
75.84
Total Liabilities
890.40
797.01
700.29
587.42
534.36
452.36
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
273.92
251.66
236.33
197.16
170.75
141.58
Less: Accumulated Depreciation
83.14
69.88
57.21
46.86
39.12
31.22
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
190.78
181.78
179.12
150.30
131.63
110.36
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
5.23
4.47
3.48
6.71
16.05
1.69
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
110.59
110.22
79.58
62.49
31.83
30.83
Other Non Current Assets
0.57
0.41
0.12
0.47
1.75
0.45
Total Non-Current Assets
307.35
297.07
262.51
220.21
181.51
143.61
Current Assets Loans & Advances
Current Investments
208.54
173.72
138.92
91.33
96.81
80.66
Inventories
80.11
78.68
77.17
70.03
72.74
46.61
Sundry Debtors
161.45
166.40
161.77
136.33
115.94
113.35
Cash and Bank
32.66
22.43
13.83
34.32
18.80
13.84
Other Current Assets
1.58
3.15
1.62
1.96
0.53
1.22
Short Term Loans and Advances
98.73
55.57
44.47
33.25
48.03
53.06
Total Current Assets
583.06
499.94
437.78
367.21
352.85
308.75
Net Current Assets (Including Current Investments)
472.01
393.72
345.50
295.07
262.36
232.91
Total Current Assets Excluding Current Investments
374.52
326.22
298.87
275.89
256.04
228.09
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
890.40
797.01
700.29
587.42
534.36
452.36
Contingent Liabilities
4.48
3.12
0.23
0.23
0.23
2.30
Total Debt
4.42
0.00
1.07
2.00
2.04
0.52
Book Value per share (adjusted)
0
335.34
295.98
250.86
216.12
182.92
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 19.48% vs 48.90% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 5.24% vs 2.00% in Mar 2025

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 16.63% vs 14.20% in Mar 2025

Compare Balance Sheet Results of Lincoln Pharma.
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
20.03
0
20.03
0.00%
Share Warrants & Outstandings
Total Reserve
737.60
0
737.60
0.00%
Shareholder's Funds
757.63
0
757.63
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
0.00
0
0.00
0.00%
Secured Loans
0.00
0
0.00
0.00%
Unsecured Loans
0.00
0
0.00
0.00%
Deferred Tax Assets / Liabilities
13.53
0
13.53
0.00%
Other Long Term Liabilities
6.44
0
6.44
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
1.76
0
1.76
0.00%
Total Non-Current Liabilities
21.73
0
21.73
0.00%
Current Liabilities
Trade Payables
84.86
0
84.86
0.00%
Other Current Liabilities
15.65
0
15.65
0.00%
Short Term Borrowings
4.42
0
4.42
0.00%
Short Term Provisions
6.11
0
6.11
0.00%
Total Current Liabilities
111.04
0
111.04
0.00%
Total Liabilities
890.40
0
890.40
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
273.92
0
273.92
0.00%
Less: Accumulated Depreciation
83.14
0
83.14
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
190.78
0
190.78
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
5.23
0
5.23
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.00
0
0.00
0.00%
Long Term Loans & Advances
110.59
0
110.59
0.00%
Other Non Current Assets
0.57
0
0.57
0.00%
Total Non-Current Assets
307.35
0
307.35
0.00%
Current Assets Loans & Advances
Current Investments
208.54
0
208.54
0.00%
Inventories
80.11
0
80.11
0.00%
Sundry Debtors
161.45
0
161.45
0.00%
Cash and Bank
32.66
0
32.66
0.00%
Other Current Assets
1.58
0
1.58
0.00%
Short Term Loans and Advances
98.73
0
98.73
0.00%
Total Current Assets
583.06
0
583.06
0.00%
Net Current Assets (Including Current Investments)
472.01
0
472.01
0.00%
Total Current Assets Excluding Current Investments
374.52
0
374.52
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
890.40
0
890.40
0.00%
Contingent Liabilities
4.48
0
4.48
0.00%
Total Debt
4.42
0
4.42
0.00%
Book Value per share (adjusted)
0.00
0
0.00
0.00%
Annual - Borrowings
Borrowings 4.42 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 6.44 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 19.48% vs 48.90% in Mar 2025

Annual - Fixed Assets
Fixed Assets 196.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 5.24% vs 2.00% in Mar 2025

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 583.06 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.63% vs 14.20% in Mar 2025